A Long Term Safety Study With Atrasentan
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gary Gordon, MD
Abbott
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Cromedia Prime/prime Trials Vancouver Hospital
Vancouver, British Columbia, Canada
- Ken Janz Md
Burlington, Ontario, Canada
- Mcmaster Institute of Urology
Hamilton, Ontario, Canada
- Mcgill University Health Center Royal Victoria Hosptial
Montreal, Quebec, Canada
- Hoptial de Ranguell Service D'Urologie
Toulouse, Cedex, France
- University Hospital Rotterdam, Department of Urology
Rotterdam, Netherlands
- Leighton Hospital Urology Research Dept., Michael Heal Outpatients Dept.
Crewe, United Kingdom
- Prostate Oncology Specialists
Marina del Rey, California, United States
- Western Clinical Research, Inc.
Torrance, California, United States
- South Florida Medical Research
Aventura, Florida, United States
- Beth Isreal Medical Center, Phillips Ambulatory Care Ceneter
New York, New York, United States
- Viahealth Rochester General Hospital Center for Urology
Rochester, New York, United States
- Oregon Urology Specialist, Division of Clinical Research
Springfield, Oregon, United States
- University of Pittsburgh Department of Urology
Pittsburgh, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2001
- Primary completion
- —
- Completion
- 30 Jun 2007
- Last update posted
- 29 Nov 2007
- Registered enrollment
- 166
- Registry id
- NCT00127478
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.